Data sourcesSEC Form 422m ago
House PTR22m ago
SEC 13F21m ago
Robinhood Chain21m ago
ADARx Pharmaceuticals, Inc. (ADRX) · INSIDER
Public companyADARx Pharmaceuticals, Inc.
ADRXCIK 0001802369
Price$13.35
1 year-31.0%
Disclosed transactions5
Buys / sells0 / 0
Max Insider Score9
Connections with evidence6
ADRX · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 9 | MRMacLeod Alan RobertChief Scientific Officer | ADRXADARx Pharmaceuticals, Inc.Grant or award | A | — 170.7K sh | Sep 24, 2026 | Sep 28, 2026 |
| 9 | ZNZhu Rui (NMN)Chief Technology Officer | ADRXADARx Pharmaceuticals, Inc.Grant or award | A | — 512.1K sh | Sep 24, 2026 | Sep 28, 2026 traded Sep 24, 2026 | +4d | SEC Form 4 | |
| 9 | | ADRXADARx Pharmaceuticals, Inc.Grant or award | A | — 170.7K sh | Sep 24, 2026 | Sep 28, 2026 traded Sep 24, 2026 | +4d | SEC Form 4 | |
| 9 | AWAckles Robert WilliamChief People Officer | ADRXADARx Pharmaceuticals, Inc.Grant or award | A | — 85.3K sh | Sep 24, 2026 | Sep 28, 2026 traded Sep 24, 2026 | +4d | SEC Form 4 | |
| 9 | LZLi ZhenDirector, President and CEO, 10% Owner | ADRXADARx Pharmaceuticals, Inc.Grant or award | A | — 1.02M sh | Sep 24, 2026 | Sep 28, 2026 traded Sep 24, 2026 | +4d | SEC Form 4 | |
CFO and CBO · Sep 28, 2026
Li ZhenDirector, President and CEO, 10% Owner · Sep 28, 2026